Snijder, Berend

Human Haploid Cell Genetics Reveals Roles for Lipid Metabolism Genes in Nonapoptotic Cell Death

Dixon, S. J., Winter, G. E., Musavi, L. S., Lee, E. D., Snijder, B., Rebsamen, M., Superti-Furga, G., & Stockwell, B. R. (2015) · ACS Chemical Biology

Cell death mechanisms and regulationFerroptosis and cancer prognosis

Cited by 1,043

SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1

Rebsamen, M., Pochini, L., Stasyk, T., de Araújo, M. E. G., Galluccio, M., Kandasamy, R. K., Snijder, B., Fauster, A., Rudashevskaya, E. L., Bruckner, M., et al. (2015) · Nature

PI3K/AKT/mTOR signaling in cancerAutophagy in Disease and Therapy

Cited by 673

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders

Kornauth, C., Pemovska, T., Vladimer, G. I., Bayer, G., Bergmann, M., Eder, S., Eichner, R., Erl, M., Esterbauer, H., Exner, R., et al. (2022) · Cancer Discovery

Acute Myeloid Leukemia ResearchChronic Lymphocytic Leukemia Research

Cited by 206

KPC1-Mediated Ubiquitination and Proteasomal Processing of NF-κB1 p105 to p50 Restricts Tumor Growth

Kravtsova-Ivantsiv, Y., Shomer, I., Cohen-Kaplan, V., Snijder, B., Superti-Furga, G., Gonen, H., Sommer, T., Ziv, T., Admon, A., Naroditsky, I., et al. (2015) · Cell

NF-κB Signaling PathwaysUbiquitin and proteasome pathways

Cited by 117

Light-mediated discovery of surfaceome nanoscale organization and intercellular receptor interaction networks

Müller, M., Gräbnitz, F., Barandun, N., Shen, Y., Wendt, F., Steiner, S. N., Severin, Y., Vetterli, S. U., Mondal, M., Prudent, J. R., et al. (2021) · Nature Communications

Advanced Proteomics Techniques and ApplicationsMass Spectrometry Techniques and Applications

Cited by 101

Global survey of the immunomodulatory potential of common drugs

Vladimer, G. I., Snijder, B., Krall, N., Bigenzahn, J. W., Huber, K. V. M., Lardeau, C.-H., Sanjiv, K., Ringler, A., Berglund, U. W., Sabler, M., et al. (2017) · Nature Chemical Biology

Cancer Immunotherapy and BiomarkersImmunotoxicology and immune responses

Cited by 87

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

Martins, T. A., Kaymak, D., Tatari, N., Gerster, F., Hogan, S., Ritz, M.-F., Sabatino, V., Wieboldt, R., Bartoszek, E. M., McDaid, M., et al. (2024) · Nature Communications

CAR-T cell therapy researchGlioma Diagnosis and Treatment

Cited by 54

Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL

Schmidl, C., Vladimer, G. I., Rendeiro, A. F., Schnabl, S., Krausgruber, T., Taubert, C., Krall, N., Pemovska, T., Araghi, M., Snijder, B., et al. (2019) · Nature Chemical Biology

Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and Treatment

Cited by 39

Deep Morphology Learning Enhances Ex Vivo Drug Profiling-Based Precision Medicine

Heinemann, T., Kornauth, C., Severin, Y., Vladimer, G. I., Pemovska, T., Hadzijusufovic, E., Agis, H., Krauth, M.-T., Sperr, W. R., Valent, P., et al. (2022) · Blood Cancer Discovery

Digital Imaging for Blood DiseasesAcute Myeloid Leukemia Research

Cited by 28

Enhancing anti-EGFRvIII CAR T cell therapy against glioblastoma with a paracrine SIRPγ-derived CD47 blocker

Martins, T. A., Tatari, N., Kaymak, D., Hogan, S., Bartoszek, E. M., Wieboldt, R., Ritz, M.-F., Buck, A., McDaid, M., Gerber, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory)

CAR-T cell therapy researchGlioma Diagnosis and Treatment

Cited by 0